Biolator ApS: Financial statements 2020
CVR: 38609254
Biolator ApS (CVR 38609254) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -16,676 and a net result of DKK -17,038 compared with DKK 9,775 the year before. Equity amounted to DKK 17,052. The solvency ratio was 32.7%.
- Gross Profit
- -16,676 kr.
- Profit/Loss
- -17,038 kr.
- Equity
- 17,052 kr.
- Total Assets
- 52,079 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -17 t. | -17 t. | 17 t. | - |
| 2019 | - | - | 10 t. | 34 t. | 1 |
| 2018 | - | -7 t. | -7 t. | 24 t. | - |
How creditworthy is Biolator ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Biolator ApS has published its annual report for 2019. The net result was DKK 9,775.
About Biolator ApS
Biolator ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Søren Kjærulff. The company is owned by Søren Kjærulff and Diana Bak. In 2025, the company reported a gross profit of DKK -1,051,063 and a net result of DKK -931,358 compared with DKK 6,166,939 the year before. Equity amounted to DKK 114,319,691.
